




その他のタイトル Study on the pathogenesis of asthma and COPD :































研究成果の概要（英文）：Severe asthma is a heterogeneous condition. In older patients, 
asthma-COPD overlap syndrome becomes more prevalent as patients become less atopic and 
their airflow obstruction become less reversible. Airflow obstruction (FEV1) and annual 
FEV1 decline were associated with TSLP and Nrf2, respectively, in healthy adults without 
evident pulmonary diseases. Both genes, which function as sensors of outside world, are 
potential markers of an increased susceptibility to obstructive lung disease such as 
asthma and COPD. In a study of pharmacogenetics, asthma patients had variable responses 
to a combination treatment of inhaled corticosteroid with salmeterol or with montelukast, 
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った。一方、Nrf2 遺伝子における 4 個の Tag 
SNP (rs2001350, rs6726395, rs1962142, 
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